@TJQPNI@hjluks@artibiotics This structure made the first six months of my medical school career a misery! The thing that demoralised me the most was that my old dad was able to remember the anatomy and function of it 40 years after he learned it, as he was delighted to inform me…
Currently reading a great review by @MattYousefzadeh on immunosenescence, or the ageing of the immune system. While obviously relevant to the elderly, there are also important parallels to cancer as well, particularly in the context of immunotherapy: https://t.co/4dnUd676gr
@chrissyfarr Nobody sequences HIV strains anymore, or argues for single (or even dual) treatment modalities. Of course, the big challenge for cancer therapeutics in this context is going to be finding three or four agents that are tolerable for many years. (It’s what we are aiming at!)
@chrissyfarr My feeling, fwiw, is that the rapidly evolving cancers (NSCLC, PDAC etc) that aren’t curable at the moment, will be turned into chronic diseases like HIV, which, when you think about it, is an acquired genetic disease treated at diagnosis by multiple targeted therapies.
Pleased to announce our collaboration with the Phaeo and Para charity to investigate our lead drug as a potential treatment for a rare cancer with no current treatments
https://t.co/uH7hQ1i4Ch
@Biohazard3737 Ha! When I was on the wards, I saw the reverse experiment. A bunch of young bankers who had been laid off post Lehman enrolled as medical students. Turns out that the quant-types cannot make a medical decision without *all* the data…
@semodough This raises a very interesting question- can a biologically successful treatment/company be commercially successful in this space/at this price point? From the outside, fascinating. From the company/investor/patient POV, even more so…
My daughter Margot, who has a rare genetic disease that causes epilepsy, was accepted into the n-Lorem foundation! What does this mean? @n_lorem will work with @ionispharma to design an n=1 ASO specifically targeting her mutations in the SCN8A gene to treat her rare disease 1/4
The Conversatives would love you to believe that the shocking NHS waiting lists are all down to Covid
But the reality is that there was 4.4 million people on waiting lists in 2019 due to their underfunding of the NHS
Please RT if you think everyone should be clear about that
@INArteCarloDoss Salve Carlo! I’m CEO of an EU based biotech (former academic medic), looking to navigate through turbulent waters, contribute to friendly communities. Please open DMs
Immigration is America's superpower, so this should be raising alarm bells for policymakers:
The United States is no longer the top choice of foreign talent when asked where they would move for work.